N-Benzylisatin Sulfonamide Analogues as Potent Caspase-3 Inhibitors: Synthesis, in Vitro Activity, and Molecular Modeling Studies
摘要:
A number of isatin sulfonamide analogues were prepared and their potencies for inhibiting caspase-1, -3, -6, -7, and -8 were evaluated in vitro. Several compounds displaying a nanomolar potency for inhibiting the executioner caspases, caspase-3 and caspase-7, were identified. These compounds were also observed to have a low potency for inhibiting the initiator caspases, caspase-1 and caspase-8, and caspase-6. Molecular modeling studies provided further insight into the interaction of this class of compounds with activated caspase-3. The results of the current study revealed a number of non-peptide-based caspase inhibitors that may be useful in assessing the role of inhibiting the executioner caspases in minimizing tissue damage in disease conditions characterized by unregulated apoptosis.
N-Benzylisatin Sulfonamide Analogues as Potent Caspase-3 Inhibitors: Synthesis, in Vitro Activity, and Molecular Modeling Studies
摘要:
A number of isatin sulfonamide analogues were prepared and their potencies for inhibiting caspase-1, -3, -6, -7, and -8 were evaluated in vitro. Several compounds displaying a nanomolar potency for inhibiting the executioner caspases, caspase-3 and caspase-7, were identified. These compounds were also observed to have a low potency for inhibiting the initiator caspases, caspase-1 and caspase-8, and caspase-6. Molecular modeling studies provided further insight into the interaction of this class of compounds with activated caspase-3. The results of the current study revealed a number of non-peptide-based caspase inhibitors that may be useful in assessing the role of inhibiting the executioner caspases in minimizing tissue damage in disease conditions characterized by unregulated apoptosis.
Simple Chiral PyrrolidineâPyridine-Based Catalysts for Highly Enantioselective Michael Addition to Nitro Olefins
作者:Da-Zhen Xu、Sen Shi、Yongmei Wang
DOI:10.1002/ejoc.200900716
日期:2009.10
of chiral pyrrolidine–pyridine-based organocatalysts, available from commercially available starting materials, have been synthesized and shown to be very effective catalysts for the asymmetric Michaeladdition reactions of cyclic/acyclic/aromatic ketones and an aldehyde with nitro olefins, giving excellent yields (up to 99 %), diastereoselectivities (syn/anti = 99:1), and enantioselectivities (up
There is provided a novel compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity. The present invention provides an imidazothiazole derivative represented by the following formula (1) having various substituents that inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity:
wherein R
1
, R
2
, R
3
, R
4
, and R
5
in the formula (1) each has the same meaning as defined in the specification.
Pyrrolidine–pyridine base catalysts for the enantioselective Michael addition of ketones to chalcones
作者:Da-Zhen Xu、Sen Shi、Yingjun Liu、Yongmei Wang
DOI:10.1016/j.tet.2009.09.001
日期:2009.11
A series of pyrrolidine-pyridine base organocatalysts have been developed and 3a found to be a highly effective catalyst for the asymmetric Michael addition reactions of ketones to chalcones. The reaction generated the corresponding products 1, 5-diketones in excellent diastereoselectivities (up to >99:1 dr) and enantioselectivities (up to 100% ee). (c) 2009 Elsevier Ltd. All rights reserved.